Sunitinib [sunitinib]
topical
199
- Terms
-
sunitinib malát
Sutent
-
5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide
SU 011248
SU 11248
SU-011248
SU-11248
SU011248
SU11248
Sunitinib Malate
Sutent
Persistent link
https://www.medvik.cz/link/D000077210
Definition
An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
- DUI
- D000077210 MeSH Browser
- CUI
- M0448793
- History note
- 2019 (2003)
- Public note
- 2019; SUNITINIB was indexed under INDOLES and PYRROLES 2003-2018
Allowable subheadings
- AD
- administration & dosage 31
- AE
- adverse effects 26
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 3
- PD
- pharmacology 18
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 56
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.578.150
Cromakalim
D03.383.129.578.275
Duocarmycins
D03.633.100.473.250
Delavirdine
D03.633.100.473.278
Duocarmycins
D03.633.100.473.385
Hydroxytryptophol
D03.633.100.473.416
Indolosesquiterpenes
D03.633.100.473.432
Indoramin
D03.633.100.473.469
Iprindole
D03.633.100.473.629
Molindone
D03.633.100.473.725
Oxyphenisatin Acetate
D03.633.100.473.840
Sporidesmins